FDA Adverse Event Malfunction Summary report: N

ID CORE XT

MDR report key: 17893663 · Received October 9, 2023

Report

Report Number
3006413195-2023-00020
Event Type
Malfunction
Date Received
October 9, 2023
Date of Event
July 18, 2023
Report Date
October 9, 2023
Manufacturer
PROGENIKA BIOPHARMA, S.A
Product Code
PEP
UDI-DI
08437013457064
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE GENOMIC DNA SAMPLE WAS SENT TO GRIFOLS LABORATORY SOLUTION FOR DNA SEQUENCING. DNA SEQUENCING INTERROGATED SPECIFIC SEQUENCES: KEL GENE EXONS 1-9. THE KEL GENOTYPE DETECTED TWO KEL*K ALLELES IN AGREEMENT WITH ID CORE XT BUT ALSO A HOMOZYGOUS MUTATION C.1546C>T REPORTED AS KO ALLELE KEL*02N.17. THIS MUTATION IS ASSOCIATED WITH A NULL KO PHENOTYPE WHICH EXPLAINS THE SEROLOGY DISCREPANCY. ID CORE XT REPORTED A PREDICTED K+ PHENOTYPE, BUT KEL*02N.17 ALLELE IS ASSOCIATED WITH A PREDICTED K- PHENOTYPE. THIS FALSE POSITIVE RESULT OBTAINED BY ID CORE XT IS CONSIDERED A DISCREPANT RESULT AND THEN A MALFUNCTION. THIS CASE REPORT IS ASSOCIATED WITH LIMITATIONS OF ID CORE XT ASSAY, AS DESCRIBED IN THE ID CORE XT PACKAGE INSERT (SEC 1 AND 10 ASSAY LIMITATIONS).

Description of Event or Problem · 0

IT WAS REPORTED THAT THE SAMPLE 8074933, FROM MADRID BLOOD TRANSFUSION CENTER, WAS TESTED WITH SEROLOGY. THE TEST RESULT WAS NEGATIVE (K-), WHICH CONTRASTED WITH THE MOLECULAR TYPING PERFORMED ON (B)(6) 2023, USING THE ID CORE XT ASSAY WHICH PROVIDED POSITIVE RESULTS (K+) WITH ID CORE XT ANALYSIS SOFTWARE V3.0.2.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1121226 ID CORE XT ANTIGEN GENOTYPING TEST PEP PROGENIKA BIOPHARMA, S.A 0203000029 08437013457064

Patients

Seq Age Sex Outcome Treatment
1 Unknown